A model of psychosocial and cultural antecedents of blood pressure control

Journal of the National Medical Association

Volumn 94, Issue 4, 2002, Pages 236-248

  Bosworth, Hayden B ^a   Oddone, Eugene Z ^b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

Adherence; Hypertension; Interventions; Medical environment; Psychosocial factors; Social environment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; COMPARATIVE STUDY; CULTURAL FACTOR; ETHNOLOGY; FEMALE; HISPANIC; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NEGRO; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; SOCIOECONOMICS; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTIHYPERTENSIVE AGENTS; CROSS-CULTURAL COMPARISON; FEMALE; HISPANIC AMERICANS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 0036548845     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (115)

1. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150:841-845.
2. Perry H, Roccella EJ. Conference report on stroke mortality in the southeastern United States. Hypertension. 1998;31: 1206-1215.
3. Kannel W. Blood pressure as a cardiovascular risk factor. Prevention and treatment. JAMA. 1996;275:1571-1576.
4. Rahman M, Douglas JG, Wright JT Jr. Pathophysiology and treatment implications of hypertension in the African-American population. Endocrinol Metab Clin North Am. 1997;26:125-44.
5. Klag M, Whelton PK., Randall BL, et al. End-stage renal disease in African-American and white men: 16-year MRFIT findings. JAMA. 1997;277:1293-1298.
6. Singh G, Kochanek KD, MacDorman MF. Advance report of final mortality statistics. Monthly Vital Statistics Rep. 1994; 45:1-76.
7. National Heart, Lung, and Blood Institute. Fact Book Fiscal Year 1996. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, 1997.
8. U.S. Renal Data System. 1997 Annual Report. Bethesda, MD: U.S. Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Disease; 1997.
9. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275: 1557-1562.
10. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension. 1994;23:275-285.
11. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health; 1997.
12. Burt V, Whelton P., Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995:25:305-313.
13. Berlowitz D, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963.
14. Eisen S, Miller DK, Woodward RS, et al. The effects of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-1884.
15. Eraker S, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med. 1984;100:258-268.
16. Kravitz RL, Hays RD, Sherbourne CD, et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med. 1993;153:1869-1878.
17. Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: a meta-analysis of individual patient data from randomized, controlled trials. Ann Intern Med. 1997;126:761-767.
18. Hall W, Ferrario CM, Moore MA, et al. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci. 1997;313:195-209.
19. Hypertension Detection, and Follow-up Program Cooperative Group. Five-year dings of the Hypertension Detection and Follow-up Program: mortality by race-sex and blood pressure level: a further analysis. J Community Health. 1984;9:314-327.
20. Ooi W, Budner NS, Cohen H, et al. Impact of race on treatment response and cardiovascular disease among hypertensives. Hypertension. 1989;14:227-234.
21. Douglas J, Wright JT Jr. Blacks and Hypertension. Kalamazoo, MI: Upjohn Company; 1992.
22. Shulman N, Cutter G, Daugherty R, Sexton M, et al. Correlates of attendance and compliance in hypertension detection and follow-up program. Controlled Clin Trials. 1982;3:13-27.
23. Ahluwalia JS, McNagny SE, Rask KJ. Correlates of controlled hypertension in indigent, inner-city hypertensive patients. J Gen Intern Med. 1997;12:7-14.
24. Shea S, Misra D, Ehrlich MH, et al. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med. 1992;327:776-781.
25. Moy E, Bartman BA, Weir MR. Access to hypertensive care: effects of income, insurance and source of care. Arch Intern Med. 1995;155:1497-1502.
26. Stason W. Cost and quality trade-offs in the treatment of hypertension. Hypertension. 1989;12:145-148.
27. Stason WB, Shepard DS, Perry HM Jr, et al. Effectiveness and costs of veterans affairs hypertension clinics. Med Care. 1994; 32:1197-215.
28. Becker M, Maiman L. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 1975;13:10-24.
29. Rosenstock I. Enhancing patient compliance with health recommendations. J Pediatr Health Care. 1988;2:67-72.
30. Bandura A. Self-efficacy. The Exercise of Control. New York: Freeman, 1997.
31. Rosenstock I. The health belief model and preventive health behavior. Health Education Monogr. 1974;2:354-386.
32. Strecher V, De Vellis BM, Becker MH, Rosenstock IM. The role of self-efficacy in achieving health behavior change. Health Educ Q. 1986;13:73-92.
33. Bandura A. Social Foundation of Thoughts and Actions: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall; 1986.
34. Williams G, Freedman ZR, Ryan RM, Deci EL. Supporting autonomy to motivate patients with diabetes for glucose control. Diabetes Care. 1998;21:1644-1651.
35. Williams G, Rodin GC, Ryan R, et al. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol. 1998;17:269-276.
36. Bandura A, Reese LB, Adams NE. Microanalysis of action and fear arousal as a function of differential levels of perceived self-efficacy. J of Pers & Soc Psychol 1982;43:5-21.
37. Bandura A, Taylor CB, Williams SL, et al. Catecholamine secretion as a function of perceived coping self-efficacy. J Consult Clin Psychol. 1985;53:406-414.
38. Gerin W, Litt MD, Deich J, Pickering TG. Self-efficacy as a moderator of perceived control effects on cardiovascular reactivity: is enhanced control always beneficial? Psychosom Med. 1995; 57:390-7.
39. Goldstein A. The "uncooperative" patient: self-destructive behavior in hemodialysis patients. In: Farberow N, ed. The Many Faces of Suicide: Indirect Self-Destructive Behavior. New York: McGraw-Hill; 1980:89-98.
40. Oettingen G. Positive fantasy and motivation. In: Gollwitzer P, Bargh JA, eds. The Psychology of Action. New York: Guilford Press; 1996:236-259.
41. Sherbourne C, Hays RD, Ordway L, et al. Antecedents and adherence to medical recommendations: results from the Medical Outcome Study. J Behav Med. 1992;15:447-468.
42. Krantz D, Deckel AW. Coping with coronary heart disease and stroke. In: TG, Burish LB, ed. Coping with Chronic Disease. New York: Academic Press; 1983.
43. Croog SS, DS. Levine S. Denial among male heart patients. An empirical study, Psychosom Med. 1971;33:385-397.
44. Suls J, Fletcher B. The relative efficacy of avoidant and nonavoidant coping strategies: a meta-analysis. Health Psychol. 1985;4:249-289.
45. DeVellis B, Revenson TA, Blalock SJ. Rheumatic disease and women's health. In: SJ Gallant, GP Keita, R. Royak-Schaler, eds. Health Care for Women: Psychological, Social, and Behavioral Influences. Washington, DC: American Psychological Association; 1997:333-347.
46. Folkman S, Chesney M, Pollack L, Coates T. Stress, control, coping, and depressive mood in human immunodeficiency virus-positive and-negative gay men in San Francisco. J Nerv Ment Dis. 1993;181:409-416.
47. Fulde R, Junge A, Ahrens S. Coping strategies and defense mechanisms and their relevance for the recovery after discectomy. J Psychosom Res. 1995;39:819-826.
48. Kirsch I, Jungeblut A, Jenkins L, Kolstad A. Adult Literacy in America: A first Look at the Results of the National Adult Literacy Survey. Washington, DC: National Center for Education, U. S. Department of Education; 1993.
49. Williams M, Parker RM, Baker DW, et al. Inadequate functional health literacy among patients at two public hospitals. JAMA. 1995;274:1677-1682.
50. Parker R, Baker DW, Williams MV, Nurss JR. The test of functional health literacy in adults: a new instrument for measuring patients' literacy skills. J Gen Intern Med. 1995;10:537-541.
51. Baker D, Parker RM, Williams, MV, et al. The relationship of patient reading ability to self-reported health and use of services. Am J Public Health. 1997;87:1027-1030.
52. Weiss B, Hart G, McGee DL, D'Estelle S. Health status of illiterate adults: relation between illiteracy and health status among persons with low literacy skills. J Am Board Fam Pract. 1992;5:254-257.
53. Health literacy: Report of the Council on Scientific Affairs. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. JAMA. 1999; 281:552-557.
54. Williams M, Baker DW, Parker RM, Nurss JR. Relationship of functional health literacy to patients' knowledge of their chronic disease: a study of patients with hypertension and diabetes. Arch Intern Med. 1998;158:166-172.
55. Park D. Self-regulation and control of rheumatic disorders. Int Rev Health Psychol. 1994;3:189-217.
56. Salthouse T. Theoretical Perspectives in Cognitive Aging. Hillsdale, NJ: Lawrence Erlbaum; 1991.
57. Park D, Willis SL, Morrow D, et al. Cognitive function and medication usage in older adults. J Appl Geront. 1994;13:39-57.
58. Ley P. Memory for medical information. Brit J Soc Clin Psychol. 1979;18:245-255.
59. Post K, Roter D. Predictors of recall of medication regimens and recommendations for lifestyle change in elderly patients. Gerontologist. 1988;27:510-515.
60. Farmer ME, Kittner SJ, Abbott RD, et al. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. J Clin Epidemiol. 1990;43:475-480.
61. Sleath B, Roter D, Chewning B, Svarstad B. Asking questions about medication: analysis of physician-patient interactions and physician perceptions. Med Care. 1999;37:1169-1173.
62. Donovan J, Blake DR. Patient non-compliance. Deviance or reasoned decision-making? Soc Sci Med. 1992;34:507-513.
63. Fogari R, Zoppi A, Corradi L, et al. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. AmJ Hypertens. 1998;11:1244-1247.
64. Schwartz J, Gallant SJ, Keita GP, Rayak-Schaler R. Principles of geriatric medicine and gerontology. In: WR Hazzard EB, Blass JP, eds. New York: McGraw-Hill; 1994:259-276.
65. Black D, Brand RJ, Greenlick M, et al. Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. J Gerontol. 1987;42:552-557.
66. Neaton J, Grimm, RH Jr, Prineas, RJ, et al. For the Treatment of Mild Hypertension Study Research Group. Treatment of mild hypertension: final results. JAMA. 1993;270:713-724.
67. Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996;78:613-617.
68. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. JAMA. 1993;270:1819-1825.
69. DiMatteo M, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101-2107.
70. DiMatteo M, Hays RD, Gritz ER, Bastani R. Patient adherence to cancer control regimens: scale development and initial validation. Psychol Assess. 1993;5:102-112.
71. DiMatteo M. Enhancing patient adherence to medical recommendations. JAMA. 1994;271:79-83.
72. DiMatteo M, DiNicola DD. Achieving Patient Compliance. Elmsford, NY: Pergamon Press Inc; 1982.
73. Kaplan G, Kell JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation. 1993;88:1973-1998.
74. Colhoun HM, Hemingway H, Poulter NR. Socioeconomic status and blood pressure: an overview analysis. J Hum Hypertens. 1998;12:91-110.
75. Bullard R. Dumping in Dixie. Race, Class, and Environmental Quality. Boulder, CO: Westview Press, 1994.
76. Farley R, Allen WR. The Color Line and the Quality of Life in America. New York: Oxford University Press, 1989.
77. McLoyd V. The impact of economic hardship on black families and children: psychological distress, parenting, and socioemotional development. Child Develop. 1990;61:341-346.
78. Adams-Campbell L, Brambillam DJ, McKinlay SM. Correlates of the prevalence of self-reported hypertension among African-American and white women. Ethnic Dis. 1993;3:119-125.
79. Krieger N. Racial and gender discrimination: risk factors for high blood pressure? Soc Sci Med. 1990;30:1273-1281.
80. Krieger N, Sidney S. Racial discrimination and blood pressure: the CARDIA study of young black and white adults. Am J Public Health. 1996;86:1370-1378.
81. Bosworth HB. The social/environmental influences on hypertension. In: Miller JR, Lerner RM, Schiamberg LB, eds. Human Ecology: An Encyclopedia of Children, Families, Communities, and Environments. Santa Barbara, in press.
82. Bosworth HB. The relationship between ecological factors and treatment adherence. In: Miller JR, Lerner RM, Schiamberg LB, eds. Human Ecology: An Encyclopedia of Children, Families, Communities, and Environments, Santa Barbara, In press.
83. Mechanic D, Schlesinger M. The impact of managed care on patients' trust in medical care and their physicians. JAMA. 1996;275:1693-1697.
84. Kaplan S, Greenfield S, Gandek B, et al. Characteristics of physicians with participatory decision-making styles. Ann Intern Med. 1996;124:497-504.
85. Williams RB, Barefoot JC, Califf RM, et al. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA. 1992;267:520-524.
86. Bosworth HB, Schaie KW. The relationship of social environment, social networks, and health outcomes in the Seattle Longitudinal Study: two analytical approaches. J Gerontol B Psychol Sci Soc Sci. 1997;52:197-205.
87. Trevino D, Young EG, Groff J, Jone RT. The association between marital adjustment and compliance with antihypertension regimens. J Am Board Fam Pract. 1990;1:17-25.
88. Stanton A. Determinants of adherence to medical regimens by hypertensive patients. J Behav Med. 1987;10:377-394.
89. Nagy V, Wolfe, GR. Cognitive predictors of compliance in chronic disease patients. Med Care. 1984;22:912-921.
90. Strogatz D, Croft JB, James SA, et al. Social support, stress, and blood pressure in black adults. Epidemiology. 1997;8: 482-487.
91. Kamarck T, Manuck SB, Jennings JR. Social support reduces cardiovascular reactivity to psychological challenge: a laboratory model. Psychosom Med. 1990;52:42-58.
92. McNeilly M, Robinson E, Anderson M, et al. Effects of racist provocation and social support on cardiovascular reactivity in African-American women. Int J Behav Med. 1995:2.
93. Hill MN, Bone LR, Kim MT, et al. Barriers to hypertension care and control in young urban black men. Am J Hypertens. 1999;12:951-958.
94. Burke L, Dunbar-Jacobs JM, Hill MN. Compliance with cardiovascular disease prevention strategies: A review of the research. Ann Behav Med. 1997;19:239-263.
95. Dunbar-Jacob J, Dwyer K, Dunning EJ. Compliance with antihypertensive regimen: a review of the research in the 1980s. Ann Behav Med. 1991;13:31-39.
96. Miller N, Hill MN, Kottke T, et al. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95:1085-1090.
97. Hyman D, Pavlik VN, Valbona C, et al. Blood pressure measurement and antihypertensive treatment in a low-income African-American population. Am J Public Health. 1998;88:292-294.
98. Blair S, Goodyear, NN, Gibbons, LW, Cooper, KH. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA. 1984;252:487-490.
99. Joos S, Hickam DH, Gordon GH, Baker LH. Effects of physician communication intervention on patient care outcomes. J Gen Intern Med. 1996;11:147-155.
100. Kaplan S, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27:S110-127.
101. Thom D, Campbell B. Patient and physician trust: an exploratory study. J Fam Practice. 1997;44:169-176.
102. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA. 1999;282:583-589.
103. Hall J, Roter DL, Katz NR. Meta-analysis of correlates of provider behavior in medical encounters. Med Care. 1988;26:657-675.
104. Haynes R, Taylor DW, Sackett DL. Can simple clinical measurement detect patient noncompliance? Hypertension. 1980; 2:759-782.
105. Fleece L, Summers MA, Schnaper H, et al. Adherence to pharmacotherapeutic regimen: Assessment and intervention. Ala J Med Sci. 1988;25:389-393.
106. Roter DH, JA. Merisca R, Nordstrom B., et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138-61.
107. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1969.
108. Mullen P, Mains DA, Velez R. A meta-analysis of controlled trials of cardiac patient education. Patient Educ Counsel. 1992;19:143-162.
109. Woolf B. Customer Specific Marketing. New York: Rand McNally; 1992.
110. Skinner C, Stretcher VJ, Hospers H. Physician recommendations for mammography: Do tailored messages make a difference? Am J Public Health. 1994;81:43-49.
111. Prochaska J, DiClemente CC, Velicer WF, et al. Standardized, individualized, interactive and personalized selfhelp programs for smoking cessation. Health Psychol. 1993;12:399-405.
112. Strecher V, Kreuter MW, DenBoer CH, et al. The effects of computer-tailored smoking cessation messages in family practice settings. J Fam Pract. 1994;39:262-270.
113. Campbell M, DeVellis BM, Strecher VJ, et al. The impact of message tailoring on dietary behavior change for disease prevention in primary care settings. Am J Public Health. 1994;84: 783-787.
114. Rimer BK. Tailoring communications for primary care settings. Methods Information Med. 1998;37:171-177.
115. U.S. Department of Health, and Human Services. Healthy People, 2010. Washington, DC: U.S. Department of Health and Human Services, 2000.